GoodRx Holdings (GDRX) Total Liabilities (2019 - 2026)

GoodRx Holdings' Total Liabilities history runs 8 years deep, the most recent figure standing at $1.4 billion for Q1 2026.

• In Q1 2026, Total Liabilities rose 118.32% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $1.4 billion (up 118.32% YoY), while the FY2025 annual figure was $787.8 million, up 18.75% from the prior year.
• Total Liabilities came in at $1.4 billion for Q1 2026 at GoodRx Holdings, up from $787.8 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $1.4 billion in Q1 2026 to a low of $640.9 million in Q1 2025.
• A 5-year average of $794.6 million and a median of $784.0 million in 2023 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities dropped 22.11% in 2025 and jumped 118.32% in 2026, its largest moves.
• GoodRx Holdings' Total Liabilities stood at $789.8 million in 2022, then rose by 4.69% to $826.8 million in 2023, then dropped by 19.77% to $663.4 million in 2024, then increased by 18.75% to $787.8 million in 2025, then jumped by 77.62% to $1.4 billion in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $1.4 billion, $787.8 million, and $724.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison